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Dm) for same number of monitor units and identical beam 
setup. Several parameters were analyzed for the PTV: D95%, 
D5%, Dmax, V100%, V50%, Homogeneity Index HI=D5%/D95% and 
Conformity Indices 100% and 50% CIX%=VX%/VPTV. Following the 
dose constraints from the AAPM TG101, values were reported 
for various critical organs: spinal cord, oesophagus, heart, 
great vessels, trachea and large bronchus, ribs and healthy 
lungs. Two-tailed paired t-tests were used to analyze the 
differences between AXB (Dw) and AAA (Dw) and between AXB 
(Dm) and AXB (Dw). F-tests were used to compare the 
variances of the populations. A significance level α=0.05 was 
chosen. 
Results: For PTV, statistically significant differences were 
observed between AAA (Dw) and AXB (Dw) for V100%, V50% and 
CI100%. While V100% was higher for AXB (Dw), V50% was lower. D95%, 
V100%, CI100% and HI values were lower for AXB (Dm) compared 
to AXB (Dw). Variance analyses showed significant differences 
in HI in all cases. For OAR, AXB (Dw) doses were lower than 
AAA (Dw), except for ribs, were photoelectric effect is 
correctly predicted by AXB. On the other hand AXB (Dm) doses 
were lower than AXB (Dw). Not all these differences were 
significant. F-tests showed no differences in populations 
variances. Observed differences arise from AXB superior 
radiation transport modelling and the effects of mapping CT 
images to materials in AXB. All these differences are not 
clinically relevant as they are comparable to dose calculation 
uncertainties, but plan normalization based on isodose 
coverage may be altered. 
Conclusions: Several statistically significant differences can 
be observed in dose prescription and dose-volume reporting 
to the PTV and OAR of lung SBRT treatments between AXB 
(Dw), AAA (Dw) and AXB (Dm). These differences are not 
clinically relevant although plan normalization may be 
altered.  
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Purpose/Objective: The aim of this study was to evaluate 
and compare the efficiency between two different VMAT 
techniques for stereotactic body radiotherapy (SBRT) in 
peripheral lung tumors. 
Materials and Methods: Five patients with a single peripheral 
lung tumor smaller than 50 cc (range 12.4, 48.6 cc) were 
included in this study. Two different VMAT plans were 
created for each patient. The first plan was performed using 
one-arc rotating 360º (1ARC). The second plan was performed 
using one-arc rotating 180º, from 180º to 0º, at the ipsilateral 
side of the affected lung (1SEMIARC). Both plans were 
calculated by the Monaco treatment planning system (version 
3.30.01), using 6 MV photons generated from Elekta Synergy 
Beam Modulator linac. Three risk-adapted fractionation 
schemes were used (3 fractions of 18 Gy, 3 fractions of 16 
Gy, and 5 fractions of 10 Gy). The objectives for PTV and 
organs at risk (OAR) matched to those used in ROSEL 
protocol. Both plans were normalized to deliver 100% of 
prescribed dose to 98% of PTV. Dosimetry comparison was 
made in terms of the percentage of healthy lung receiving a 
minimum biological equivalent dose of 20 Gy (HLV20) and the 
percentage of contralateral lung receiving a minimum 
biological equivalent dose of 5 Gy (CLV5). Paddick conformity 
index (PCI), RTOG homogeneity index (HI) and the maximum 
absorbed dose to spinal cord, esophagus and heart were also 
compared. Monitor units per gray (MU/Gy) and treatment 
delivery time (TDT), excluding any time needed for 
additional imaging and set-up, were also measured for 
treatment delivery efficiency comparison. A descriptive 
analysis (mean ± SD) of every variable was obtained for both 
plans in each patient. Dosimetry comparison between both 
plans was performed using a two-sided Student's t test. 
Differences were considered statistically significant if p < 
0.05. 
Results: DVH analysis revealed that all plans created for each 
patient fulfilled the specified dose constraints. TDT was 
reduced by 27.3 % (p < 0.001) for 1SEMIARC compared with 
1ARC, for the 18 Gy fraction scheme. 1SEMIARC plans 
achieved lower CLV5 compared with 1ARC plans (difference of 
49.9%, p < 0.02) 1SEMIARC plans showed similar PCI, HI, HLV20 
and maximum doses to the OARs compared with 1ARC plans 




Table I: Summary of study parameters between the two 
treatment techniques (mean ± SD) 
 
Conclusions: The result of this study comparing two different 
VMAT techniques for the treatment of peripheral lung 
tumors, confirms the ability of one-arc VMAT field, rotating 
180º at the ipsilateral side of the lung, to deliver highly 
conformed dose distributions. In addition to the dosimetric 
gains in the contralateral lung, one-arc VMAT field rotating 
180º technique achieve a shorter treatment time, 
accomplishing a reduction of the risk of intrafraction baseline 
shifts in tumor position, compared with one-arc VMAT field 
rotating 360º technique. 
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Purpose/Objective: To assess both plan quality criteria and 
optimization efficiency of automatically generated VMAT 
treatment plans for prostate cancer including seminal 
vesicles and lymph nodes. 
Materials and Methods: Manually (MP) and automatically (AP) 
generated VMAT treatment plans (Pinnacle© TPS V9.10, 
X4170 Smart-Enterprise) were compared for 10 prostate 
cancer cases. Each treatment plan (TP) contained a primary 
target volume (PTV) including prostate, seminal vesicles and 
